The present disclosure relates to methods for determining the renal glomerular filtration rate or assessing the renal function in a patient in need thereof. The method comprises administering, subcutaneously or intramuscularly, a pyrazine compound of Formula I to a patient, wherein the administration produces a plasma concentration of the compound that is substantially similar to a plasma concentration produced by intravenous administration of an identical amount of the compound; and monitoring the rate in which the kidneys of the patient eliminate the pyrazine from the systemic circulation of the patient. The pyrazine compound fluoresces when exposed to electromagnetic radiation which may be detected using one or more sensors. The rate in which the fluorescence decreases in the patient may be used to calculate the renal glomerular filtration rate in the patient.
本公开涉及用于确定患者的肾小球滤过率或评估其肾功能的方法。该方法包括将式I的
吡嗪化合物经皮下或肌肉注射给予患者,其中给药产生的化合物血浆浓度与相同量的化合物经静脉注射产生的血浆浓度基本相似;并监测患者肾脏从全身循环中清除
吡嗪的速率。当
吡嗪化合物暴露于电磁辐射时,其会发出荧光,可以使用一个或多个传感器检测。患者体内荧光减少的速率可以用于计算患者的肾小球滤过率。